Characterization and immunological determination of the complex between prostate-specific antigen and α2-macroglobulin

Clinical Chemistry

Volumn 44, Issue 12, 1998, Pages 2471-2479

  Zhang, Wan Ming ^a   Finne, Patrik ^a   Leinonen, Jari ^a   Vesalainen, Satu ^a   Nordling, Stig ^a   Rannikko, Sakari ^a   Stenman, Ulf Håkan ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; IMMUNOADSORPTION; MAJOR CLINICAL STUDY; MALE; PH; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN DENATURATION;

EID: 0031677840     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.12.2471     Document Type: Article

References (32)

1. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a human prostate-specific antigen. Investig Urol 1979;17:159-63.
2. Watt KW, Lee PJ, M'Timkulu T, Chan WP, Loor R. Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc Natl Acad Sci U S A 1986;83:3166-70.
3. Schaller J, Akiyama K, Tsuda R, Marti T, Rickli EE. Isolation, characterization and amino-acid sequence of γ-seminaprotein, a glycoprotein from human seminal plasma. Eur J Biochem 1987; 170:111-30.
4. Lundwall A, Lilja H. Molecular cloning of human prostate-specific antigen cDNA. FEBS Lett 1987;214:317-22.
5. Henttu P, Vihko P. cDNA coding for the entire human prostate-specific antigen shows high homologies to the human tissue kallikrein genes. Biochem Biophys Res Commun 1989;160:903-10.
6. Christensson A, Laurell CB, Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 1990;194:755-63.
7. Christensson A, Lilja H. Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen. Eur J Biochem 1994;220:45-53.
8. Leinonen J, Zhang W-M, Stenman U-H. Complex formation between PSA isoenzymes and protease inhibitors. J Urol 1996;155: 1099-103.
9. Zhang W-M, Leinonen J, Kalkkinen N, Stenman U-H. Prostate-specific antigen forms a complex with and cleaves alpha-1-protease inhibitor in vitro. Prostate 1997;33:87-96.
10. Stenman U-H, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991;51:222-6.
11. Lilja H, Christensson A, Dahlen U, Matikainen MT, Nilsson O, Pettersson K, Lövgren T. Prostate-specific antigen in serum occurs predominantly in complex with alpha-1-antichymotrypsin. Clin Chem 1991;37:1618-25.
12. Pettersson K, Piironen T, Seppälä M, Liukkonen L, Christensson A, Matikainen MT, et al. Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha-1-antichymotrypsin complex. Clin Chem 1995;41:1480-8.
13. Leinonen J, Lövgren T, Vornanen T, Stenman U-H. Double-label time-resolved immunofluorometric assay of prostate-specific antigen and of its complex with alpha-1-antichymotrypsin. Clin Chem 1993;39:2098-103.
14. Christensson A, Björk T, Nilsson O, Dahlen U, Matikainen MT, Cockett AT, et al. Serum prostate-specific antigen complexed to alpha-1-antichymotrypsin as an indicator of prostate cancer. J Urol 1993;150:100-5.
15. Barrett AJ, Brown MA, Sayers CA. The eletrophoretically 'slow' and 'fast' forms of the alpha-2-macroglobulin molecule. Biochem J 1979;181:401-18.
16. Sottrup-Jensen L. Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation. J Biol Chem 1989; 264:11539-42.
17. 2-macroglobulins. Three modes of trypsin binding. FEBS Lett 1981;128:127-32.
18. Barrett AJ, Starkey PM. The interaction of alpha-2-macroglobulin with proteinases: characteristics and specificity of the reaction and a hypothesis concerning its molecular mechanism. Biochem J 1973;133:709-24.
19. Miyata K, Nakamura M, Tomoda K. Interaction between serratia protease and human plasma alpha-2-macroglobulin. J Biochem 1981;89:1231-7.
20. Zhou AM, Tewari PC, Bluestein BI, Caldwell GW, Larsen FL. Multiple forms of prostate-specific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays. Clin Chem 1993;39:2483-91.
21. Zhang W-M, Leinonen J, Kalkkinen N, Dowell B, Stenman U-H. Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid. Clin Chem 1995;41:1567-73.
22. Kurecki T, Kress LF, Laskowski M. Purification of human alpha-2-macroglobulin and alpha-1-proteinase inhibitor using zinc chelate chromatography. Anal Biochem 1979;99:415-20.
23. Laemmli UK. Cleavage of structure proteins during the assemble of the head bacteriophage T4. Nature 1970;227:680-5.
24. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979;76: 4350-4.
25. Stenman U-H, Hakama M, Knekt P, Aromaa A, Teppo L, Leinonen J. Serum concentrations of prostate-specific antigen and its complex with alpha-1-antichymotrypsin before diagnosis of prostate cancer. Lancet 1994;344:1594-8.
26. Platt EJ, Karlsen K, Lopez-Valdivieso A, Cook PW, Firestone GL. Highly sensitive immunoadsorption procedure for detection of low-abundance proteins. Anal Biochem 1986;156:126-35.
27. 2-macroglobulin receptor/LDL receptor-related protein. J Urol 1998; 159:297-303.
28. Espana F, Sanchez CJ, Estelles A, Gilabert J, Griffin JH, Heeb MJ. Quantitative immunoassay for complexes of prostate-specific antigen with alpha-2-macroglobulin. Clin Chem 1996;42:545-50.
29. 2-macroglobulin in human blood. J Immunol Methods 1993;162:59-64.
30. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317:909-16.
31. Oesterling JE, Chan DW, Epstein JI, Kimball AW, Bruzek DJ, Rock RC, et al. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 1988;139:766-72.
32. Stenman UH. Prostate-specific antigen, clinical use and staging: an overview. Br J Urol 1997;79(Suppl 1):53-60.